Tucker Chandra L, Ramamurthy Visvanathan, Pina Ana-Luisa, Loyer Magali, Dharmaraj Sharola, Li Yingying, Maumenee Irene H, Hurley James B, Koenekoop Robert K
Department of Biochemistry, University of Washington, Seattle, WA, USA.
Mol Vis. 2004 Apr 20;10:297-303.
Recessive mutations in GUCY2D, the gene encoding the retinal guanylyl cyclase protein, RetGC-1, have been shown to cause Leber Congenital Amaurosis (LCA), a severe retinal dystrophy. The purpose of this study was to determine the functional consequences of selected mutations in GUCY2Dlinked to LCA. The mutations investigated in this study map to the catalytic domain (P858S, L954P) and the extracellular domain (C105Y, L325P) of RetGC-1.
All four mutations were introduced into the in vitro expression plasmid, pRC-CMV human RetGC-1, and expressed in HEK-293 cells. We assayed the abilities of the mutant cyclases to generate cGMP (basal activity), and to be activated by guanylyl cyclase activating proteins (GCAP-1 and GCAP-2). Additionally, we co-expressed the catalytic domain mutations (P858S and L954P) with a wild-type allele to test for dominant negative effects on wild-type RetGC-1.
The P858S and L954P mutations, both in highly conserved residues of the catalytic domain of RetGC-1, severely impair basal, GCAP-1, and GCAP-2 stimulated catalytic activity of the enzyme. In addition, when co-expressed with the wild-type allele, both catalytic domain mutations act as dominant negative proteins and reduce the activity of wild-type RetGC-1. The basal activities of the C105Y and L325P mutants are unaltered, but GCAP-1 and GCAP-2 stimulated cyclase activities are reduced approximately 50%.
GUCY2D mutations from LCA patients have distinct functional consequences on RetGC-1 catalytic activity in vitro. Our analyses showed that the catalytic domain mutations cause a marked reduction in cyclase activity, while the extracellular domain mutations moderately reduce activity. The catalytic domain mutant alleles cause dominant negative effects, indicating that the functionality of RetGC-1 is compromised even in heterozygotes. This is consistent with abnormalities in cone electroretinograms (ERGs) detected in obligate heterozygous GUCY2D parents that carry the L954P mutation.
编码视网膜鸟苷酸环化酶蛋白RetGC-1的基因GUCY2D中的隐性突变已被证明会导致严重的视网膜营养不良——莱伯先天性黑蒙(LCA)。本研究的目的是确定与LCA相关的GUCY2D中特定突变的功能后果。本研究中所研究的突变位于RetGC-1的催化结构域(P858S、L954P)和细胞外结构域(C105Y、L325P)。
将所有四个突变引入体外表达质粒pRC-CMV人RetGC-1,并在HEK-293细胞中表达。我们检测了突变型环化酶产生环磷酸鸟苷(cGMP)的能力(基础活性),以及被鸟苷酸环化酶激活蛋白(GCAP-1和GCAP-2)激活的能力。此外,我们将催化结构域突变(P858S和L954P)与野生型等位基因共表达,以测试其对野生型RetGC-1的显性负效应。
RetGC-1催化结构域高度保守残基中的P858S和L954P突变严重损害了该酶的基础活性、GCAP-1和GCAP-2刺激的催化活性。此外,当与野生型等位基因共表达时,两个催化结构域突变均表现为显性负性蛋白,并降低野生型RetGC-1的活性。C105Y和L325P突变体的基础活性未改变,但GCAP-1和GCAP-2刺激的环化酶活性降低了约50%。
LCA患者的GUCY2D突变在体外对RetGC-1催化活性具有不同的功能后果。我们的分析表明,催化结构域突变导致环化酶活性显著降低,而细胞外结构域突变则适度降低活性。催化结构域突变等位基因产生显性负效应,表明即使在杂合子中RetGC-1的功能也受到损害。这与携带L954P突变的GUCY2D义务杂合子父母中检测到的视锥细胞视网膜电图(ERG)异常一致。